创伤性脑损伤中二氧化碳反应指数的可视化与解读
该回顾性观察分析在单中心成人及儿童创伤中心纳入218例中重度创伤性脑损伤患者(178例成人、40例儿童),通过60分钟窗口内颅内压与呼气末二氧化碳的移动Pearson相关计算二氧化碳反应指数。颅内压≤20 mm Hg且呼气末二氧化碳30–40 mm Hg时该指数中位数为0.27(四分位距0.20–0.37),而颅内压>20 mm Hg且呼气末二氧化碳20–30 mm Hg时中位数为0.09(四分位距-0.02至0.15)。该指数与脑灌注压在60–75 mm Hg时呈正相关(r=0.31,P<0.001),预后良好者该指数更高。作者认为该指数可能有助于检测自动调节功能障碍并指导个体化通气、二氧化碳控制及手术决策,但需前瞻性验证。
要点
- 颅内压≤20 mm Hg且呼气末二氧化碳30–40 mm Hg时二氧化碳反应指数中位数为0.27(IQR 0.20–0.37),提示代谢反应性保留。
- 颅内压>20 mm Hg且呼气末二氧化碳20–30 mm Hg时二氧化碳反应指数中位数为0.09(IQR -0.02至0.15),提示反应性受损。
- 二氧化碳反应指数与脑灌注压在60–75 mm Hg时呈正相关(r=0.31,P<0.001)。
- 预后良好的患者二氧化碳反应指数更高,尤其在颅内压和呼气末二氧化碳最佳范围内。
- 作者认为该指数可能有助于检测自动调节功能障碍并指导个体化通气、二氧化碳控制及手术决策,需前瞻性验证。
适用人群与场景
- 纳入单中心成人及儿童创伤中心收治的中度和重度创伤性脑损伤患者,共218例(178例成人、40例儿童)。
研究设计与关键结果
- 研究类型为回顾性观察分析,纳入218例中重度创伤性脑损伤患者(178例成人、40例儿童),来自单中心成人及儿童创伤中心。
- 二氧化碳反应指数通过60分钟窗口内颅内压与呼气末二氧化碳的移动Pearson相关计算,使用低频时间序列数据。
- 颅内压≤20 mm Hg且呼气末二氧化碳30–40 mm Hg时,二氧化碳反应指数中位数为0.27(IQR 0.20–0.37)。
- 颅内压>20 mm Hg且呼气末二氧化碳20–30 mm Hg时,二氧化碳反应指数中位数为0.09(IQR -0.02至0.15)。
- 二氧化碳反应指数与脑灌注压在60–75 mm Hg时呈正相关(r=0.31,P<0.001)。
- 预后良好的患者二氧化碳反应指数更高,尤其在颅内压和呼气末二氧化碳最佳范围内;较低值则与较差预后相关。
证据类型、等级与局限
- 证据类型:回顾性观察分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为二氧化碳反应指数可能有助于检测自动调节功能障碍,并指导个体化通气、二氧化碳控制及手术决策。
- 作者指出需前瞻性验证以确认其临床相关性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cerebral autoregulation is routinely assessed through variations in intracranial pressure (ICP) and systemic hemodynamic parameters; however, its metabolic dimension remains underexplored in clinical settings. This study introduces the carbon dioxide reactivity index (CO2Rx), a novel metric derived from continuous ICP and end-tidal CO2 (ETCO2) monitoring aimed at capturing real-time cerebrovascular metabolic reactivity in patients with severe traumatic brain injury (TBI).
METHODS: We performed a retrospective observational analysis of patients with moderate and severe TBI admitted to a single adult and pediatric trauma center. CO2Rx was calculated as a moving Pearson correlation between ICP and ETCO2 across 60-min windows using low-frequency time-series data. Heatmaps and contour plots visualized median CO2Rx values across ICP and ETCO2 ranges. Analyses were stratified by age, decompressive craniectomy status, and 12-month outcomes. A graphical framework linked CO2Rx/ICP/ETCO2 combinations to outcome probabilities.
RESULTS: A total of 218 patients (178 adults, 40 pediatric patients) were included. Higher CO2Rx values, indicative of preserved metabolic reactivity, were observed when ICP was ≤ 20 mm Hg, and ETCO2 ranged between 30 and 40 mm Hg (median: 0.27; interquartile range [IQR]: 0.20-0.37). In contrast, elevated ICP (> 20 mm Hg) and reduced ETCO2 (20-30 mm Hg) were associated with lower CO2Rx values (median: 0.09; IQR: - 0.02 to 0.15), suggesting impaired reactivity. A positive correlation emerged between CO2Rx and cerebral perfusion pressure, peaking at 60-75 mm Hg (r = 0.31; p < 0.001). Patients with favorable outcomes displayed higher CO2Rx values, especially within optimal ICP and ETCO2 ranges, whereas lower values were associated with poorer outcomes.
CONCLUSIONS: CO2Rx is a promising marker of cerebrovascular metabolic reactivity in TBI, offering novel insights into the dynamic relationship between ICP and ETCO2. It may aid in detecting autoregulatory dysfunction and guide individualized strategies for ventilation, CO2 control, and surgical decisions. Prospective validation is warranted to confirm its clinical relevance.
CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT05043545.
参考来源
- Gritti P, Bonfanti M, Zangari R, et al. Visualizing and Interpreting the Carbon Dioxide Reactivity Index in Traumatic Brain Injury. Neurocrit Care. 2026. PMID: 41507673. doi:10.1007/s12028-025-02429-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。